Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Elsevier survey highlights challenges faced by physicians in finding trusted clinical search engines

Nine out of 10 physicians in Asia-Pacific use some form of online search to aid clinical decision-making, with Google being the most popular and frequently used non-evidence based search engine.

3 Sep 2015

Children's Hospital Los Angeles receives $2 million to spur research on brain, spinal cord tumors

A life-changing event for a Los Angeles family has resulted in their funding an endowment to support The Kort Family Foundation Brain and Spinal Cord Tumor Research Program in the Division of Neurosurgery at Children's Hospital Los Angeles.

3 Sep 2015

Boca Raton Regional Hospital introduces ultra-minimally invasive procedure for patients with atrial fibrillation

Boca Raton Regional Hospital's Richard G. Cartledge, MD, FACS, has begun performing ultra-minimally invasive left atrial appendage ligation for atrial fibrillation patients who are on anticoagulants such as Coumadin, Xarelto or Effient. Dr. Cartledge, who is Chief of Cardiothoracic Surgery at the Hospital, is one of a select group of surgeons nationally using this method, which involves making two microscopic incisions in order to seal off the left atrial appendage (LAA) in patients where anticoagulants are contraindicated or who refuse to be on such medications.

3 Sep 2015

Prime Healthcare Services acquires St. Joseph Mercy Port Huron

Prime Healthcare Services, the fastest growing hospital system in the nation, announced today that it has completed the acquisition of St. Joseph Mercy Port Huron. As a result, St. Joseph Mercy Port Huron will now be known as Lake Huron Medical Center.

3 Sep 2015

Allergan announces positive results from AVYCAZ Phase III studies for treatment of cUTI

Allergan plc. today announced positive topline results from RECAPTURE 1 and 2, the pivotal Phase III studies evaluating the antibiotic AVYCAZ (ceftazidime-avibactam) as a treatment for adult hospitalized patients with complicated urinary tract infections (cUTI), including pyelonephritis.

2 Sep 2015

Incorporating clinical genomic sequencing data into clinical management improves pediatric cancer treatment

In a study that included children and young adults with relapsed or refractory cancer, incorporation of integrative clinical genomic sequencing data into clinical management was feasible, revealed potentially actionable findings in nearly half of the patients, and was associated with change in treatment and family genetics counseling for a small proportion of patients, according to a study in the September 1 issue of JAMA.

2 Sep 2015

UCLA scientists develop promising new combination treatment for glioblastoma

UCLA scientists have developed a potentially promising new combination therapy for glioblastoma, the deadliest form of brain cancer.

2 Sep 2015

U-M study suggests potential treatment options for children with aggressive, advanced cancer

For children with rare, aggressive and advanced cancer, precision medicine may help doctors determine their best treatment options, a new study finds.

2 Sep 2015

Men with relatively unaggressive prostate tumors unlikely to develop metastatic prostate cancer

Men with relatively unaggressive prostate tumors and whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to results of a study by researchers at the Brady Urological Institute at Johns Hopkins, who analyzed survival statistics up to 15 years.

1 Sep 2015

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar Therapeutics announced today that it has received a $40 million cash payment under a license agreement with AstraZeneca. The payment was triggered by the first commercial sale of MOVENTIG (naloxegol) in Germany.

1 Sep 2015

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients with Atrial Fibrillation), their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation (NVAF).

1 Sep 2015

Experts to discuss research on lupus at world congress organized by MedUni Vienna

Lupus is an autoimmune disease with so many different symptoms that it is often difficult to diagnose and to treat. Despite huge medical advances over the last few years, lupus is incurable. Modern, individually tailored therapeutic approaches are aimed at helping sufferers. The world congress organized by MedUni Vienna brings experts from more than 80 countries together in Vienna from 2 to 6 September to discuss the latest research results and therapies.

1 Sep 2015

Northwestern University receives $11.7 million NCI grant to use nanotechnology for cancer treatments

Northwestern University, a leader in cancer nanotechnology research, has received a five-year, $11.7 million grant from the National Cancer Institute to use nanotechnology to develop next-generation cancer treatments.

1 Sep 2015

Jersey Shore to break ground on HOPE Tower to provide new healing outpatient experience for the community

Jersey Shore University Medical Center, part of the Meridian Health family, is preparing to break ground this fall on the HOPE Tower Project - a $265 million dollar building development on the hospital's east campus that will provide a new healing outpatient experience for the community. HOPE Tower's expected date of completion is early 2018.

1 Sep 2015

Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today it has completed enrollment of the additional subjects, as directed by the Data Review Committee (DRC) earlier this year, into the company's Phase 2 study for SGX942.

31 Aug 2015

Brain tumor is not always the death sentence

Only half of brain cancers actually start in the brain. The rest - as in the case of former president Jimmy Carter - are metastatic tumors from cancer that originated elsewhere in the body.

29 Aug 2015

Moffitt researchers hope to improve pancreatic cancer survival rates by developing blood test to identify IPMNs

Pancreatic cancer is the fourth most common cause of cancer-related death in the United States and has a 5-year survival rate of only 6 percent, which is the lowest rate of all types of cancer according to the American Cancer Society.

29 Aug 2015

New European project creates different tools to manage healthcare through technology

The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.

28 Aug 2015

LLS, Light The Night National Corporate Partner Teams make positive impact on patients' lives

The Leukemia & Lymphoma Society is working with thousands of national partners, sponsors and corporate teams to fund lifesaving research and support for people battling cancer through the Light The Night Walk. Together with LLS, the Light The Night National Corporate Partner Teams are raising awareness and making a positive impact on the lives of patients today, literally, by taking steps to save lives.

28 Aug 2015

Genetic test that predicts recurrence of breast cancer may impact use of chemotherapy

A genetic test that helps predict whether some women's breast cancer will recur might influence how chemotherapy is used, according to a study from Duke Medicine.

28 Aug 2015

Oncology News and Research

Further Reading

Elsevier survey highlights challenges faced by physicians in finding trusted clinical search engines

Children's Hospital Los Angeles receives $2 million to spur research on brain, spinal cord tumors

Boca Raton Regional Hospital introduces ultra-minimally invasive procedure for patients with atrial fibrillation

Prime Healthcare Services acquires St. Joseph Mercy Port Huron

Allergan announces positive results from AVYCAZ Phase III studies for treatment of cUTI

Incorporating clinical genomic sequencing data into clinical management improves pediatric cancer treatment

UCLA scientists develop promising new combination treatment for glioblastoma

U-M study suggests potential treatment options for children with aggressive, advanced cancer

Men with relatively unaggressive prostate tumors unlikely to develop metastatic prostate cancer

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Experts to discuss research on lupus at world congress organized by MedUni Vienna

Northwestern University receives $11.7 million NCI grant to use nanotechnology for cancer treatments

Jersey Shore to break ground on HOPE Tower to provide new healing outpatient experience for the community

Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Brain tumor is not always the death sentence

Moffitt researchers hope to improve pancreatic cancer survival rates by developing blood test to identify IPMNs

New European project creates different tools to manage healthcare through technology

LLS, Light The Night National Corporate Partner Teams make positive impact on patients' lives

Genetic test that predicts recurrence of breast cancer may impact use of chemotherapy

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News